A trophoblast glycoprotein specific 5T4-Vδ2 bispecific T cell engager recruits Vγ9Vδ2-T cells for tumor-selective cytotoxicity across solid malignancies
Clinical Immunology · 2026-06 · 285 · 110707
DOI: 10.1016/j.clim.2026.110707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology, 2026-06. Verfasst von Milon de Jong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and …. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, gamma-delta, T-Lymphocytes, Antibodies, Bispecific, Neoplasms. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LAVA Therapeutics.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands; Amsterdam institute for Infect…
- Lava Therapeutics, Utrecht, the Netherlands.
- Department of Urology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands; Oncode Institute, Amsterdam, t…
- Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.
- Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands; Lava Therapeutics, Utrecht, th…
Förderung
- LAVA Therapeutics
Zitieren
APA
de Jong, M., Žiberna, R., Veth, M., Michielon, E., Myrda, J., Seidel, J., Akbarzadeh, M., van Helden, P. M., Vis, A. N., Derks, S., Lameris, R., de Gruijl, T. D., & van der Vliet, H. J. (2026). A trophoblast glycoprotein specific 5T4-Vδ2 bispecific T cell engager recruits Vγ9Vδ2-T cells for tumor-selective cytotoxicity across solid malignancies. Clinical Immunology, 285, 110707. https://doi.org/10.1016/j.clim.2026.110707
Vancouver
de Jong M, Žiberna R, Veth M, Michielon E, Myrda J, Seidel J, et al. A trophoblast glycoprotein specific 5T4-Vδ2 bispecific T cell engager recruits Vγ9Vδ2-T cells for tumor-selective cytotoxicity across solid malignancies. Clinical Immunology. 2026;285:110707. doi:10.1016/j.clim.2026.110707
BibTeX
@article{deJong2026,
author = {de Jong, Milon and Žiberna, Rok and Veth, Myrthe and Michielon, Elisabetta and Myrda, Julia and Seidel, Jens and Akbarzadeh, Maryam and van Helden, Pauline M and Vis, André N and Derks, Sarah and Lameris, Roeland and de Gruijl, Tanja D and van der Vliet, Hans J},
title = {A trophoblast glycoprotein specific 5T4-Vδ2 bispecific T cell engager recruits Vγ9Vδ2-T cells for tumor-selective cytotoxicity across solid malignancies},
journal = {Clinical Immunology},
year = {2026},
volume = {285},
pages = {110707},
doi = {10.1016/j.clim.2026.110707}
}
EUVIMED